MyFinsight
Home
Blog
About
Contact
Download
Download image
Net gain
attributable to common...
-$12,544K
(10.28%↑ Y/Y)
Net gain
-$10,544K
(11.99%↑ Y/Y)
Paid-in-kind dividend on
series c convertible...
$2,000K
(0.00%↑ Y/Y)
Biologistics Solutions
$21,668K
(16.93%↑ Y/Y)
Biostorage Bioservices
$5,230K
(20.67%↑ Y/Y)
Loss from continuing
operations
-$9,432K
(-4.47%↓ Y/Y)
Gain from
discontinued operations, net
-$1,112K
(62.34%↑ Y/Y)
Investment income
$3,090K
(96.44%↑ Y/Y)
Service
$26,898K
(17.64%↑ Y/Y)
Product
$20,900K
(14.99%↑ Y/Y)
Loss from continuing
operations before...
-$9,324K
(-6.03%↓ Y/Y)
Provision for income taxes
$108K
(-53.85%↓ Y/Y)
Total other income,
net
$290K
(-57.97%↓ Y/Y)
Total revenue
$47,798K
(16.47%↑ Y/Y)
Other expense, net
-$2,368K
(-689.33%↓ Y/Y)
Interest expense, net
$432K
(-25.90%↓ Y/Y)
Loss from operations
-$9,614K
(-1.37%↓ Y/Y)
Gross margin
$21,913K
(17.55%↑ Y/Y)
Total cost of revenue
$25,885K
(15.56%↑ Y/Y)
Total operating costs
and expenses
$31,527K
(12.10%↑ Y/Y)
Service
$13,747K
(-39.88%↓ Y/Y)
Product
$12,138K
(-33.22%↓ Y/Y)
Selling, general and
administrative
$27,620K
(14.17%↑ Y/Y)
Engineering and development
$3,907K
(-0.69%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Cryoport, Inc. (CYRX)
Cryoport, Inc. (CYRX)